
Nymox Pharmaceutical Corporation NYMX
Annual report 2024
added 03-21-2026
Country |
|
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
- |
Market Cap[1] |
$ 18.4 M |
EBITDA (LTM) |
$ -13.8 M |
P/E (LTM) |
- |
P/S (LTM) |
195.6 |
EPS (LTM) |
-0.17 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market | ||
|
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | ||
|
AbbVie
ABBV
|
$ 208.84 | -2.86 % | $ 369 B | NYSE,SPB | ||
|
AbCellera Biologics
ABCL
|
$ 3.52 | 0.28 % | $ 1.05 B | Nasdaq Global Select Market | ||
|
Grifols, S.A.
GRFS
|
$ 8.24 | -0.12 % | $ 6.83 B | Nasdaq Global Select Market | ||
|
Ascendis Pharma A/S
ASND
|
$ 229.25 | 0.44 % | $ 5 B | Nasdaq Global Select Market | ||
|
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | ||
|
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market | ||
|
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | ||
|
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | ||
|
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | ||
|
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | ||
|
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | ||
|
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | ||
|
ANI Pharmaceuticals
ANIP
|
$ 74.21 | -2.3 % | $ 1.43 B | Nasdaq Global Market,SPB | ||
|
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | ||
|
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | ||
|
Autolus Therapeutics plc
AUTL
|
$ 1.41 | 2.17 % | $ 375 M | Nasdaq Global Select Market | ||
|
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | ||
|
Cocrystal Pharma
COCP
|
$ 1.51 | 48.04 % | $ 17 M | Nasdaq Capital Market | ||
|
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | ||
|
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | ||
|
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | ||
|
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX | ||
|
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | ||
|
BioMarin Pharmaceutical
BMRN
|
$ 55.5 | -3.04 % | $ 10.6 B | Nasdaq Global Select Market,SPB | ||
|
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | ||
|
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | ||
|
Arcturus Therapeutics Holdings
ARCT
|
$ 8.03 | 2.29 % | $ 220 M | Nasdaq Global Market,SPB | ||
|
Adaptive Biotechnologies Corporation
ADPT
|
$ 14.81 | 2.63 % | $ 2.25 B | Nasdaq Global Select Market,SPB | ||
|
Altimmune
ALT
|
$ 3.34 | 7.05 % | $ 294 M | Nasdaq Global Market | ||
|
BioNTech SE
BNTX
|
$ 91.18 | 1.97 % | $ 27.2 B | Nasdaq Global Select Market | ||
|
Amgen
AMGN
|
$ 347.94 | -1.51 % | $ 187 B | Nasdaq Global Select Market,SPB | ||
|
Aurinia Pharmaceuticals
AUPH
|
$ 15.61 | 0.9 % | $ 2.1 B | Nasdaq Global Market | ||
|
Bristol-Myers Squibb Company
BMY
|
$ 59.6 | -2.45 % | $ 121 B | NYSE,SPB | ||
|
Aptose Biosciences
APTO
|
- | -45.71 % | $ 1.2 M | Nasdaq Capital Market | ||
|
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | ||
|
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | ||
|
Burford Capital Limited
BUR
|
$ 4.14 | -2.59 % | $ 683 M | NYSE | ||
|
BioCryst Pharmaceuticals
BCRX
|
$ 9.02 | -3.84 % | $ 1.86 B | Nasdaq Global Select Market | ||
|
Avenue Therapeutics
ATXI
|
- | -52.27 % | $ 4.45 M | Nasdaq Global Select Market | ||
|
Atea Pharmaceuticals
AVIR
|
$ 5.76 | 1.95 % | $ 469 M | Nasdaq Global Select Market | ||
|
BeiGene, Ltd.
BGNE
|
- | 0.49 % | $ 251 B | Nasdaq Global Select Market | ||
|
AVROBIO
AVRO
|
- | 1083.1 % | $ 745 M | Nasdaq Global Select Market | ||
|
Cellectis S.A.
CLLS
|
$ 3.41 | 1.19 % | $ 116 M | Nasdaq Global Market | ||
|
Biogen
BIIB
|
$ 177.34 | -3.5 % | $ 26 B | Nasdaq Global Select Market,SPB | ||
|
Axcella Health
AXLA
|
- | -16.42 % | $ 249 M | Nasdaq Global Market | ||
|
Axon Enterprise
AXON
|
$ 412.81 | -2.54 % | $ 31.3 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.